Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471923 · ClinicalTrials.gov registry record
Non-Motor Features of Cervical Dystonia (CD)
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 33
- Enrollment target
NCT03471923: Completed study, sponsored by Vanderbilt University Medical Center.
NCT03471923 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03471923 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
This study will examine the prevalence of four previously identified non-motor markers in a population of cervical dystonia patients, unaffected family members, and healthy volunteers in an attempt to identify a distinct combination of non-motor symptoms that may be indicative of disease development.
Primary Outcome
For participants in all groups, the investigators will examine the prevalence of spatial discrimination threshold. Prevalence of spatial discrimination threshold will be determined with a task using Johnson-Van-Boven-Phillips (JVP) domes. The spatial discrimination threshold will be recorded as the mean of both hands at the 75% level of accuracy. The research coordinator will report prevalence of spatial discrimination threshold as a descriptive statistic.
Interventions
- DIAGNOSTIC_TEST Neurological Examination
- DIAGNOSTIC_TEST Assessment of Non-Motor Features
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2019-12-02 |
What the finished NCT03471923 record still lists
NCT03471923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Neurological Examination is the first listed.
NCT03471923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03471923 about?
NCT03471923 is a clinical study titled "Non-Motor Features of Cervical Dystonia (CD)". This study will examine the prevalence of four previously identified non-motor markers in a population of cervical dystonia patients, unaffected family members, and healthy volunteers in an attempt to identify a distinct combination of non-motor symptoms that may be indicative of disease development...
What is the current status of trial NCT03471923?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2018-03-26. Estimated completion is 2019-12-02.
What interventions are being tested in trial NCT03471923?
The interventions under investigation include: Neurological Examination (DIAGNOSTIC_TEST), Assessment of Non-Motor Features (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03471923?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI